SCHEMBL3854867

SCHEMBL3854867

Cc1n[nH]cc1-c1ccc2ncnc(N3CCN(CCc4ccccc4)CC3)c2c1

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AURKA O14965 2/20 0.60
ALDH1A1 P00352 12/20 0.53
CYP1A2 P05177 12/20 0.53
CYP3A4 P08684 12/20 0.53
CLK4 Q9HAZ1 9/20 0.53
HIF1A Q16665 8/20 0.53
MAPK1 P28482 8/20 0.53
LMNA P02545 8/20 0.53
TSHR P16473 7/20 0.53
USP2 O75604 5/20 0.53
MEN1 O00255 4/20 0.53
KMT2A Q03164 4/20 0.53
CYP2C19 P33261 10/20 0.51
CYP2D6 P10635 5/20 0.51
KDM4E B2RXH2 2/20 0.51
HPGD P15428 2/20 0.51
SMN1; SMN2 Q16637 1/20 0.51
HSD17B10 Q99714 2/20 0.50
ACHE P22303 1/20 0.47
BACE1 P56817 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3846275 0.91 HTT (0.50) AURKAALDH1A1CYP1A2CYP3A4CLK4
SCHEMBL3847428 0.91 ACHE (0.58) AURKAALDH1A1CYP1A2CYP3A4CLK4
SCHEMBL3851339 0.84 CYP3A4 (0.67) ALDH1A1CYP1A2CYP3A4CLK4HIF1A
SCHEMBL3850182 0.82 AURKA (0.60) AURKAALDH1A1CYP1A2CYP3A4CLK4
SCHEMBL30734213 0.81 ACHE (0.57) ALDH1A1CYP1A2CYP3A4CLK4HIF1A
SCHEMBL3847066 0.81 CYP1A2 (0.61) ALDH1A1CYP1A2CYP3A4CLK4HIF1A
SCHEMBL3852832 0.81 ACHE (0.55) AURKAALDH1A1CYP1A2CYP3A4CLK4
SCHEMBL3847901 0.80 CYP1A2 (0.53) ALDH1A1CYP1A2CYP3A4CLK4HIF1A
SCHEMBL3852842 0.79 KIT (0.42) ALDH1A1CYP1A2CYP3A4CLK4HIF1A
SCHEMBL3846258 0.79 CYP1A2 (0.52) ALDH1A1CYP1A2CYP3A4CLK4HIF1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2048142-A2 Nitrogen-containing condensed cyclic compound having a pyrazolyl group as a substituent group and pharmaceutical composition thereof Eisai R&D Management Co., Ltd. (JP) 2009-04-15 EP disclosed
EP-1382603-B1 NITROGENOUS FUSED-RING COMPOUND HAVING PYRAZOLYL GROUP AS SUBSTITUENT AND MEDICINAL COMPOSITION THEREOF EISAI R&D MAN CO LTD (JP) 2008-07-23 EP disclosed
US-7074801-B1 Nitrogen-containing condensed cyclic compound having a pyrazolyl group as a substituent group and pharmaceutical composition thereof EISAI CO., LTD. (JP) 2006-07-11 US disclosed
EP-1382603-A1 NITROGENOUS FUSED−RING COMPOUND HAVING PYRAZOLYL GROUP AS SUBSTITUENT AND MEDICINAL COMPOSITION THEREOF Eisai Co., Ltd. (JP) 2004-01-21 EP disclosed